These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30220049)

  • 21. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
    Kurczab R; Bojarski AJ
    J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants.
    Ntie-Kang F; Simoben CV; Karaman B; Ngwa VF; Judson PN; Sippl W; Mbaze LM
    Drug Des Devel Ther; 2016; 10():2137-54. PubMed ID: 27445461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
    Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
    J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Task-Specific Scoring Functions for Predicting Ligand Binding Poses and Affinity and for Screening Enrichment.
    Ashtawy HM; Mahapatra NR
    J Chem Inf Model; 2018 Jan; 58(1):119-133. PubMed ID: 29190087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ligand- and structure-based virtual screening on the DUD data set.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2009 Feb; 49(2):209-31. PubMed ID: 19434824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure- and Ligand-Based Virtual Screening on DUD-E
    Cleves AE; Jain AN
    J Chem Inf Model; 2020 Sep; 60(9):4296-4310. PubMed ID: 32271577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S; Schneider G
    J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.
    Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U
    J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.
    Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P
    J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Assessment of Predictive Accuracies of Conventional and Machine Learning Scoring Functions for Protein-Ligand Binding Affinity Prediction.
    Ashtawy HM; Mahapatra NR
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(2):335-47. PubMed ID: 26357221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-based G Protein Coupled Receptor pharmacophore modeling: Assessing the role of ligand function in model development.
    Castleman P; Szwabowski G; Bowman D; Cole J; Parrill AL; Baker DL
    J Mol Graph Model; 2022 Mar; 111():108107. PubMed ID: 34915346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators.
    Yang JM; Shen TW
    Proteins; 2005 May; 59(2):205-20. PubMed ID: 15726586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A scalable and accurate method for classifying protein-ligand binding geometries using a MapReduce approach.
    Estrada T; Zhang B; Cicotti P; Armen RS; Taufer M
    Comput Biol Med; 2012 Jul; 42(7):758-71. PubMed ID: 22658682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theoretical and practical considerations in virtual screening: a beaten field?
    Kontoyianni M; Madhav P; Suchanek E; Seibel W
    Curr Med Chem; 2008; 15(2):107-16. PubMed ID: 18220766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore alignment search tool: influence of scoring systems on text-based similarity searching.
    Hähnke V; Schneider G
    J Comput Chem; 2011 Jun; 32(8):1635-47. PubMed ID: 21328403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.